Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
52 hedge funds and large institutions have $31.5M invested in Augmedix, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 39 closing their positions.
85% more call options, than puts
Call options by funds: $24K | Put options by funds: $13K
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
38% less funds holding
Funds holding: 84 → 52 (-32)
81% less capital invested
Capital invested by funds: $162M → $31.5M (-$130M)
82% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 39
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.65M |
| 2 |
SM
Samjo Management
New York
|
+$1.49M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
+$1.07M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$577K |
| 5 |
WCA
Whetstone Capital Advisors
Shawnee Mission,
Kansas
|
+$486K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.16M |
| 2 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$2.15M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$2.01M |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$1.82M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.52M |
AUGX Hedge Fund Activity: Q2 2024 in Review
52 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q2 2024, worth a combined $31.5M — down 81% from $162M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of AUGX and 7 opened new positions — a net loss of 32 holders — while 22 trimmed existing stakes and 18 added.
The largest buyer was Schonfeld Strategic Advisors, adding an estimated $1.65M. The largest seller was Essex Investment Management, exiting entirely with an estimated $2.16M sold.
- 52 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q2 2024, down from 84 in Q1 2024.
- Funds reported $31.5M of Augmedix, Inc. Common Stock stock for Q2 2024, down 81% quarter-over-quarter.
- 7 funds opened new Augmedix, Inc. Common Stock positions in Q2 2024 and 39 closed out, a net change of -32 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q2 2024 was Schonfeld Strategic Advisors, an estimated $1.65M added.
- The largest Augmedix, Inc. Common Stock seller in Q2 2024 was Essex Investment Management, an estimated $2.16M sold.
Based on aggregated 13F filings for Q2 2024.